purpose: to evaluate the beneficial effects of rifampin for the treatment of central serous chorioretinopathy (cscr). methods: in this non-randomized clinical trial, 39 patients with acute cscr (<2 weeks) were enrolled. initially, complete visual examinations including determination of best spectacle-corrected visual acuity (bscva) using snellen chart; anterior and posterior segment examination...

purpose : to evaluate the correlation between inner segment/outer segment (is/os) line and external limiting membrane (elm) layer integrity at foveal center and visual outcome and to investigate the prognostic factors in optical coherence tomography (oct) that related to final visual acuity (va) and recovery time in acute central serous chorioretinopathy (csc) methods : we prospectively studied...

Central serous chorioretinopathy is a common acquired maculopathy. Multiple studies showed that photodynamic therapy is useful treatment for acute and chronic central serous chorioretinopathy. The exact mechanism of photodynamic therapy in treating central serous chorioretinopathy is not clear, but it is thought to be caused by short-term choriocapillaris hypoperfusion and long-term choroidal v...

central serous chorioretinopathy (cscr) is an ocular disease which fluid is collected under retina and leads to retinal detachment and blurred vision. risk factors for development of central serous chorioretinopathy are included: alcohol use, uncontrolled hypertension, pregnancy, type a personalityand different ways of corticosteroid use. we want to present central serous chorioretinopathy in a...

PURPOSE To evaluate the influence of clinical and multimodal imaging parameters on the duration of acute central serous chorioretinopathy (CSCR) episodes. METHODS Consecutive patients with first, treatment-naïve central serous chorioretinopathy episodes presenting within 20 days of symptoms onset were prospectively included. They were reevaluated 15 days to 20 days later, followed by monthly ...

Central serous chorioretinopathy is a relatively common retinal disease characterized by the accumulation of subretinal fluid at the posterior pole of the fundus, creating a circumscribed area of serous retinal detachment. It typically affects young and middle-aged men with no previous medical and family history, and no systemic symptoms or signs. However, it has been noted that central serous ...

AIMS To report the beneficial effect of intravitreal bevacizumab (Avastin) injection in patients with acute central serous chorioretinopathy. METHODS Ten eyes of 10 patients with acute central serous chorioretinopathy received an intravitreal bevacizumab (1.25 mg/0.05 ml) injection. At baseline and follow-up visits patients had best corrected visual acuity (BCVA), IOP assessment, dilated fund...

PURPOSE To quantify retinal fluorescence lifetimes in patients with central serous chorioretinopathy (CSC) and to identify disease specific lifetime characteristics over the course of disease. METHODS Forty-seven participants were included in this study. Patients with central serous chorioretinopathy were imaged with fundus photography, fundus autofluorescence, optical coherence tomography, a...

BACKGROUND Central serous chorioretinopathy is a disorder often related to systemic corticosteroids, drugs commonly used in rheumatologists' clinical practice. Central serous chorioretinopathy prognosis is generally good but in some cases, it may lead to substantial loss of vision resulting in an important functional limitation for patients. It is very important to distinguish this pathology fr...